Zai Lab Ltd
HKEX:9688
Intrinsic Value
Zai Lab Ltd is a CN-based company operating in Biotechnology industry. [ Read More ]
The intrinsic value of one Zai Lab Ltd stock under the Base Case scenario is 35.5 HKD. Compared to the current market price of 12.38 HKD, Zai Lab Ltd is Undervalued by 65%.
Valuation Backtest
Zai Lab Ltd
Run backtest to discover the historical profit from buying and selling Zai Lab Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Zai Lab Ltd
Current Assets | 939.6m |
Cash & Short-Term Investments | 806.5m |
Receivables | 65.3m |
Other Current Assets | 67.8m |
Non-Current Assets | 96.7m |
Long-Term Investments | 9.2m |
PP&E | 68.6m |
Intangibles | 16.5m |
Other Non-Current Assets | 2.4m |
Current Liabilities | 203.1m |
Accounts Payable | 113m |
Accrued Liabilities | 40.8m |
Other Current Liabilities | 49.3m |
Non-Current Liabilities | 37.1m |
Other Non-Current Liabilities | 37.1m |
Earnings Waterfall
Zai Lab Ltd
Revenue
|
266.7m
USD
|
Cost of Revenue
|
-95.8m
USD
|
Gross Profit
|
170.9m
USD
|
Operating Expenses
|
-547.5m
USD
|
Operating Income
|
-376.6m
USD
|
Other Expenses
|
42m
USD
|
Net Income
|
-334.6m
USD
|
Free Cash Flow Analysis
Zai Lab Ltd
Profitability Score
Profitability Due Diligence
Zai Lab Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Score
Zai Lab Ltd's profitability score is 30/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Zai Lab Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Score
Zai Lab Ltd's solvency score is 81/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Zai Lab Ltd
According to Wall Street analysts, the average 1-year price target for Zai Lab Ltd is 40.68 HKD with a low forecast of 15.15 HKD and a high forecast of 70.16 HKD.
Shareholder Return
Price
Zai Lab Ltd
Average Annual Return | -10.17% |
Standard Deviation of Annual Returns | 70.62% |
Max Drawdown | -93% |
Market Capitalization | 12B HKD |
Shares Outstanding | 992 086 976 |
Percentage of Shares Shorted |
N/A
|
News
Last Important Events
Zai Lab Ltd
Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.
Sentiment Analysis
Zai Lab Ltd
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Zai Lab Ltd is a CN-based company operating in Biotechnology industry. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The firm is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The firm has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.
Contact
IPO
Employees
Officers
The intrinsic value of one Zai Lab Ltd stock under the Base Case scenario is 35.5 HKD.
Compared to the current market price of 12.38 HKD, Zai Lab Ltd is Undervalued by 65%.